Abstract
Patients with diabetes and chronic kidney disease including end-stage kidney disease, and kidney transplant recipients are at increased risk of severe COVID-19 infection, hospitalization and premature death. Both diabetes and CKD exert synergistic effect on increasing the patient’s susceptibility towards risk of COVID-19 infection. The Global Burden of Disease collaboration (GBD) and WHO have declared CKD and diabetes as the most prevalent risk factors for severe COVID-19. Hence, management should focus on both infection prevention and treatment. Several studies and adequate evidence from literature is available on the impact of COVID-19 disease on diabetes alone or CKD alone. However, many data is not available on COVID-19 disease impact on diabetic CKD patients. This short review article focuses on understanding the impact of COVID-19 on diabetic CKD patients and other aspects such as pathophysiology, epidemiology, prevention and management of diabetic CKD patients with COVID-19 infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: IP Journal of Nutrition, Metabolism and Health Science
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
